Viloxazine
RxNorm 11196
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 11196 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Viloxazine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing viloxazine (medicinal product)
(Atom ID: 10319572)
INPrescribable
Ingredient (IN):
Viloxazine
(Atom ID: 12252823)
PTPrescribable
Designated preferred name (PT):
Viloxazine
(Atom ID: 2385507)
FNPrescribable
Full form of descriptor (FN):
Viloxazine (substance)
(Atom ID: 2385508)
PTPrescribable
Designated preferred name (PT):
Viloxazine-containing product
(Atom ID: 10822608)
Patient Education
Viloxazine
Viloxazine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children 6 to 17 years of age with attention deficit hyperactivity disorder (ADHD). Viloxazine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.
[Learn More]
* Please review the disclaimer below.